mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.9 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.017 |
0.9 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |